Seeing Is Believing
Currently out of the existing stock ratings of Tyler Van Buren, 204 are a BUY (80.31%), 45 are a HOLD (17.72%), 5 are a SELL (1.97%).
Analyst Tyler Van Buren, currently employed at TD COWEN, carries an average stock price target met ratio of 39.27% that have a potential upside of 21.3% achieved within 147 days.
Tyler Van Buren’s has documented 491 price targets and ratings displayed on 48 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on REGN, Regeneron Pharmaceuticals at 23-Jul-2024.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 2/24/2021. The price target of $19.43 was fulfilled within 2 days with a profit of $2.64 (15.72%) receiving and performance score of 78.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
12
$5.06 (72.91%)
30
18 days ago
1/5 (20%)
$5.24 (77.51%)
35
Buy
30
$23.06 (332.28%)
30
18 days ago
0/3 (0%)
$23.24 (343.79%)
Buy
40
$33.06 (476.37%)
4
1 months 13 days ago
1/4 (25%)
$30.52 (321.94%)
543
Buy
22
$15.06 (217.00%)
40
4 months 2 days ago
2/5 (40%)
$12.47 (130.85%)
52
Buy
6
$4.05 (207.69%)
4
11 months 26 days ago
4/7 (57.14%)
$4.22 (237.08%)
196
Which stock is Tyler Van Buren is most bullish on?
Which stock is Tyler Van Buren is most reserved on?
What Year was the first public recommendation made by Tyler Van Buren?